Piedmont Pathology Associates Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Piedmont Pathology Associates and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 45 Piedmont Pathology Associates employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Piedmont Pathology Associates has purchased the following applications: Lumen CDN for Content Delivery Network in 2017 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Piedmont Pathology Associates is running and its propensity to invest more and deepen its relationship with Lumen Technologies or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Piedmont Pathology Associates revenues, which have grown to $5.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Piedmont Pathology Associates intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.